NEW YORK (GenomeWeb) – A seven-gene test for breast cancer risk could be cost-effective in improving life expectancy among women with a family history of disease, according to a new study from Quest Diagnostic researchers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.